Home / Resources / Discovery resources

药物发现

最新资源

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Chemaxon presents: Too Many Tools, Not Enough Chemistry

Chemaxon presents: Too Many Tools, Not Enough Chemistry

网络研讨会点播

Migrating to Chemaxon Java Libraries 26: What Changed and How to Adapt

Migrating to Chemaxon Java Libraries 26: What Changed and How to Adapt

Precursor Chemicals - Sine qua non

Precursor Chemicals – Sine qua non

精选资源

Precursor Chemicals - Sine qua non

Precursor Chemicals – Sine qua non

Latest discovery blogs

All Discovery - Blog

Not Just Another ChatGPT: Why Life Sciences Needs Domain-Specific AI

Mathematical Modeling and the Monkey King: Use of Modeling for More Efficient NHP Study Design

4 Ways That Mechanistic Modeling Accelerates Bispecific (and Multispecific) Antibody Drug Development

Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome

药物发现平台开启科学数据访问之路

药物发现工具如何助力药物研发决策制定

在以下活动中与我们的专家会面

Bio International Convention 2026

2026 年 6 月 22 - 25 日 — 波士顿，马萨诸塞州 — 展位 1304

Certainty China 2026

2026 年 6 月 25 日 – Shanghai, China

Mechanistic MIDD: Achieving Regulatory Success Through Strong Scientific Foundations

2026 年 6 月 30 日 – 12:00 PM – 2:00 PM

All Discovery resources

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Poster

Chemaxon presents: Too Many Tools, Not Enough Chemistry

Certara Products, On-Demand Webinar

Precursor Chemicals – Sine qua non

Discovery, Blog

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Certara Services, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM

Certara Products, Model Informed Drug Development, Modeling and Simulation, Blog

2026 Simcyp Workshops

Certara Products - Simcyp, Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Brochure

Applying AI-Driven Biosimulation to Drug Discovery

Biologics, Certara Products, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Video

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

Biologics, Certara Products - Certara IQ, Modeling and Simulation - QSP, Publication

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Certara Products - Certara IQ, Certara Products - Simcyp, Drug Development, Drug-Drug Interactions (DDI), ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), On-Demand Webinar

生命科学领域 AI 提示词工程（Prompt Engineering）最佳实践

Certara Products, Certara.AI, Blog

利用 PBPK 建模预测 FcRn 介导的药代动力学/药效学

Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Poster

利用 PBPK 模型预测眼部药物的行为

Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Poster

1
2
3
……
26
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software